Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $57.8B |
| FY2017, ended Dec 31, 2017 | $66.0B |
| FY2018, ended Dec 31, 2018 | $51.3B |
| FY2019, ended Dec 31, 2019 | $58.9B |
| FY2020, ended Dec 31, 2020 | $72.6B |
| FY2021, ended Dec 31, 2021 | $71.7B |
| FY2022, ended Dec 31, 2022 | $65.4B |
| FY2023, ended Dec 31, 2023 | $65.6B |
| FY2024, ended Dec 31, 2024 | $73.8B |
| FY2025, ended Dec 31, 2025 | $63.3B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $73.1B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $15.2B |
| FY2017, ended Dec 31, 2017 | $15.5B |
| FY2018, ended Dec 31, 2018 | $15.5B |
| FY2019, ended Dec 31, 2019 | $15.7B |
| FY2020, ended Dec 31, 2020 | $16.5B |
| FY2021, ended Dec 31, 2021 | $17.4B |
| FY2022, ended Dec 31, 2022 | $18.0B |
| FY2023, ended Dec 31, 2023 | $19.5B |
| FY2024, ended Dec 31, 2024 | $20.1B |
| FY2025, ended Dec 31, 2025 | $20.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $21.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.44B | $2.55B |
| FY2017, ended Dec 31, 2017 | $2.02B | $2.50B |
| FY2018, ended Dec 31, 2018 | $2.40B | $2.62B |
| FY2019, ended Dec 31, 2019 | $2.37B | $2.80B |
| FY2020, ended Dec 31, 2020 | $2.69B | $3.31B |
| FY2021, ended Dec 31, 2021 | $2.17B | $2.76B |
| FY2022, ended Dec 31, 2022 | $1.78B | $1.86B |
| FY2023, ended Dec 31, 2023 | $2.30B | $3.04B |
| FY2024, ended Dec 31, 2024 | $2.89B | $3.55B |
| FY2025, ended Dec 31, 2025 | $2.13B | $3.63B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.04B | $3.86B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.31B |
| FY2017, ended Dec 31, 2017 | $1.53B |
| FY2018, ended Dec 31, 2018 | $726M |
| FY2019, ended Dec 31, 2019 | $883M |
| FY2020, ended Dec 31, 2020 | $888M |
| FY2021, ended Dec 31, 2021 | $832M |
| FY2022, ended Dec 31, 2022 | $775M |
| FY2023, ended Dec 31, 2023 | $966M |
| FY2024, ended Dec 31, 2024 | $1.10B |
| FY2025, ended Dec 31, 2025 | $1.29B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.37B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.52B |
| FY2017, ended Dec 31, 2017 | $6.57B |
| FY2018, ended Dec 31, 2018 | $6.35B |
| FY2019, ended Dec 31, 2019 | $7.59B |
| FY2020, ended Dec 31, 2020 | $7.34B |
| FY2021, ended Dec 31, 2021 | $7.21B |
| FY2022, ended Dec 31, 2022 | $8.76B |
| FY2023, ended Dec 31, 2023 | $8.24B |
| FY2024, ended Dec 31, 2024 | $7.00B |
| FY2025, ended Dec 31, 2025 | $7.84B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $7.82B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 9.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 883M |
| FY2017, ended Dec 31, 2017 | 875M |
| FY2018, ended Dec 31, 2018 | 862M |
| FY2019, ended Dec 31, 2019 | 855M |
| FY2020, ended Dec 31, 2020 | 849M |
| FY2021, ended Dec 31, 2021 | 840M |
| FY2022, ended Dec 31, 2022 | 830M |
| FY2023, ended Dec 31, 2023 | 823M |
| FY2024, ended Dec 31, 2024 | 812M |
| FY2025, ended Dec 31, 2025 | 802M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 797M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.33B | $123M |
| FY2017, ended Dec 31, 2017 | $1.40B | $127M |
| FY2018, ended Dec 31, 2018 | $1.24B | $109M |
| FY2019, ended Dec 31, 2019 | $1.20B | $100M |
| FY2020, ended Dec 31, 2020 | $1.48B | $107M |
| FY2021, ended Dec 31, 2021 | $1.32B | $135M |
| FY2022, ended Dec 31, 2022 | $1.31B | $125M |
| FY2023, ended Dec 31, 2023 | $1.13B | $122M |
| FY2024, ended Dec 31, 2024 | $1.74B | $135M |
| FY2025, ended Dec 31, 2025 | $1.21B | $155M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.29B | $178M |
Valuation
At current price- Market Cap
- $73.5B
- P/E
- 36.1×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.5×
- Price / Book
- 311×
- EV / EBITDA
- 21.2×
Growth
Trailing 12 months- Revenue (TTM)
- $21.0B
- Revenue Growth YoY
- 5.2%
- Revenue CAGR 3Y
- 4.3%
- Revenue CAGR 5Y
- 4.4%
- EPS Growth YoY
- −28.7%
- Net Income Growth YoY
- −29.9%
Profitability
Trailing 12 months- Gross Margin
- 60.4%
- Operating Margin
- 14.9%
- Net Margin
- 9.7%
- FCF Margin
- 18.3%
- Return on Equity
- 435%
Earnings
Trailing 12 months- Net Income
- $2.04B
- EPS (diluted)
- $2.54
- EBITDA
- $3.77B
- Operating Income
- $3.13B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $1.37B
- Total Debt
- $7.82B
- Net Debt
- $6.45B
- Total Assets
- $16.8B
- Total Liabilities
- $16.2B
- Shareholders' Equity
- $236M
Cash Flow
Trailing 12 months- Operating Cash Flow
- $4.46B
- Capital Expenditure
- $598M
- Free Cash Flow
- $3.86B
Dividends and risk
Last 12 months- Dividend Yield
- 2.3%
- Dividend / Share
- $2.11
- Beta (5Y)
- 0.33
Every ratio is calculated from the company’s reported figures.